We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
125 hedge funds and large institutions have $2.34B invested in MyoKardia, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 51 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
194% more call options, than puts
Call options by funds: $6.24M | Put options by funds: $2.13M
34% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 38
34% more capital invested
Capital invested by funds: $1.75B → $2.34B (+$587M)
27% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 15
3% more funds holding
Funds holding: 121 → 125 (+4)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
125
Holders Change
+4
Holders Change %
+3.31%
% of All Funds
2.86%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.16%
New
19
Increased
51
Reduced
38
Closed
15
Calls
$6.24M
Puts
$2.13M
Net Calls
+$4.12M
Net Calls Change
+$3.76M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.6M |
| 2 |
BlackRock
New York
|
+$13.2M |
| 3 |
D.E. Shaw & Co
New York
|
+$8.72M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$8.62M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.03M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$16.4M |
| 2 |
DM
Deerfield Management
New York
|
-$14.2M |
| 3 |
SC
Samlyn Capital
New York
|
-$8.48M |
| 4 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
-$8.05M |
| 5 |
JP Morgan Chase
New York
|
-$7.38M |
